TaiwanJ Pharmaceuticals Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 21.556 million. Operating income was TWD 7.507 million compared to operating loss of TWD 19.522 million a year ago. Net income was TWD 5.010 million compared to net loss of TWD 22.121 million a year ago. Basic earnings per share was TWD 0.07 compared to basic loss per share of TWD 0.32 a year ago.